IL42317A - Pharmaceutical preparations active against depression and insomnia,containing l-5-hydroxytryptophan together with n1-(d,l-seryl)-n2-(2,3,4,-trihydroxybenzyl)-hydrazine - Google Patents

Pharmaceutical preparations active against depression and insomnia,containing l-5-hydroxytryptophan together with n1-(d,l-seryl)-n2-(2,3,4,-trihydroxybenzyl)-hydrazine

Info

Publication number
IL42317A
IL42317A IL42317A IL4231773A IL42317A IL 42317 A IL42317 A IL 42317A IL 42317 A IL42317 A IL 42317A IL 4231773 A IL4231773 A IL 4231773A IL 42317 A IL42317 A IL 42317A
Authority
IL
Israel
Prior art keywords
seryl
hydrazine
trihydroxybenzyl
hydroxytryptophan
pharmaceutically acceptable
Prior art date
Application number
IL42317A
Other languages
English (en)
Other versions
IL42317A0 (en
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Publication of IL42317A0 publication Critical patent/IL42317A0/xx
Publication of IL42317A publication Critical patent/IL42317A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL42317A 1972-06-30 1973-05-21 Pharmaceutical preparations active against depression and insomnia,containing l-5-hydroxytryptophan together with n1-(d,l-seryl)-n2-(2,3,4,-trihydroxybenzyl)-hydrazine IL42317A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH984672 1972-06-30

Publications (2)

Publication Number Publication Date
IL42317A0 IL42317A0 (en) 1973-07-30
IL42317A true IL42317A (en) 1976-04-30

Family

ID=4356299

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42317A IL42317A (en) 1972-06-30 1973-05-21 Pharmaceutical preparations active against depression and insomnia,containing l-5-hydroxytryptophan together with n1-(d,l-seryl)-n2-(2,3,4,-trihydroxybenzyl)-hydrazine

Country Status (18)

Country Link
AT (1) AT338412B (ja)
AU (1) AU476456B2 (ja)
BE (1) BE801645A (ja)
CA (1) CA1015272A (ja)
DD (1) DD107592A5 (ja)
DE (1) DE2327636A1 (ja)
ES (1) ES416383A1 (ja)
FR (1) FR2190453B1 (ja)
GB (1) GB1369189A (ja)
HU (1) HU167292B (ja)
IE (1) IE37833B1 (ja)
IL (1) IL42317A (ja)
LU (1) LU67898A1 (ja)
NL (1) NL7308435A (ja)
PH (1) PH9584A (ja)
SE (1) SE407744B (ja)
SU (1) SU533323A3 (ja)
ZA (1) ZA733284B (ja)

Also Published As

Publication number Publication date
IE37833L (en) 1973-12-30
GB1369189A (en) 1974-10-02
NL7308435A (ja) 1974-01-02
IL42317A0 (en) 1973-07-30
ES416383A1 (es) 1976-02-16
AT338412B (de) 1977-08-25
AU5589773A (en) 1974-11-21
FR2190453A1 (ja) 1974-02-01
HU167292B (ja) 1975-09-27
DD107592A5 (ja) 1974-08-12
DE2327636A1 (de) 1974-01-17
LU67898A1 (ja) 1975-04-11
PH9584A (en) 1976-01-19
AU476456B2 (en) 1976-09-23
FR2190453B1 (ja) 1976-04-09
ATA574273A (de) 1976-12-15
SU533323A3 (ru) 1976-10-25
SE407744B (sv) 1979-04-23
BE801645A (fr) 1974-01-02
CA1015272A (en) 1977-08-09
IE37833B1 (en) 1977-10-26
ZA733284B (en) 1974-03-27

Similar Documents

Publication Publication Date Title
EP1274402B1 (en) Pharmaceutical composition for the controlled release of paracetamol
HU178867B (en) Process for preparing synergetic analgetic composition containing nalbuphine and acetaminophene
HU892559D0 (en) Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient
JPH02270820A (ja) 徐放性エトドラク
ES2240033T5 (es) Comprimido matricial de liberación prolongada de trimetazidina tras su administración por vía oral
AU2001260212A1 (en) Composition
HUP0105173A2 (hu) Adagolási módszer és készítmény sürgősségi fogamzásgátlásra
JPS6357405B2 (ja)
CA1182049A (en) Apap antacid composition
TW372193B (en) Novel pharmaceutical composition for the preparation of a stable powder containing an association of acetylsalicylic acid and metoclopramide as the active ingredient
IL43820A (en) Pharmacological preparations for the treatment of deformed disabled, containing symptomatic aminophytic bronchodilators
IL42317A (en) Pharmaceutical preparations active against depression and insomnia,containing l-5-hydroxytryptophan together with n1-(d,l-seryl)-n2-(2,3,4,-trihydroxybenzyl)-hydrazine
US2427887A (en) Analgesic composition
US5292497A (en) Method of reducing chemotherapy toxicity using (methylaminopropylamino)propyl dihydrogen phosphorothioate
PT891186E (pt) Administração nasal de agentes para o tratamento de emese tardia
US2906665A (en) L-amphetamine alginate
JPS6092214A (ja) 軟カプセル充填用組成物
GB2061111A (en) Long acting pharmaceutical composition
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
US3777026A (en) N-substituted amino-n-nitroso-amino-acetonitriles as anti-anginal agents
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
IL29570A (en) Preparations for the treatment of leukoma containing a history of 5, 01 - Epoxy - H5 - Dibenzo] a, d [Cyclohapthen
JPS61200913A (ja) 制癌剤
JPH0113449B2 (ja)
GB1375806A (ja)